Formulation and development of Serratiopeptidase enteric coated tablets and analytical method validation by UV Spectroscopy [PDF]
International Journal of Analytical Chemistry, 2021 Serratiopeptidase (SRP) is a proteolytic enzyme that emerged as one of the most potent anti-inflammatory and analgesic drugs. The purpose of the present study was to formulate and evaluate enteric-coated tablets for SRP and investigate their stability ...
Vijay Kumar Panthi +3 more
doaj +4 more sources
Formulation study of duloxetine hydrochloride enteric-coated tablets [PDF]
SN Applied Sciences, 2023 During storage, duloxetine hydrochloride may have an unexpected cross reaction with enteric coated acrylic resin, which may affect the product quality.
Jiang Guowei +4 more
doaj +3 more sources
Development of Enteric-coated Tablets of Sodium 4,4'-(propnadiamido)dibenzoate
Разработка и регистрация лекарственных средств, 2022 Introduction. Enteric coat have a wide range of functions: from protecting the API from the adverse effects of the acidic environment of the stomach to targeted delivery to certain parts of the intestine in order to increase the effectiveness of the drug.
Ju. M. Kotsur +2 more
doaj +3 more sources
Development of a particle swarm optimization-backpropagation artificial neural network model and effects of age and gender on pharmacokinetics study of omeprazole enteric-coated tablets in Chinese population [PDF]
BMC Pharmacology and Toxicology, 2022 Background The effects of age and gender were explored on pharmacokinetics study of omeprazole enteric-coated tablets in Chinese population and a plasma concentration prediction model was developed.
Yichao Xu +6 more
doaj +2 more sources
Serum level of (interleukin (IL)-2, IL-10, tumor necrosis factor (TNF)-a, motilin (MTL), gastrin (GAS), pepsinogen (PG), after adjunctive treatment in patients with chronic atrophic gastritis [PDF]
Journal of Medical BiochemistryBackground: The study aimed to demonstrate the impact of traditional Chinese medicine (TCM) matrine combined with omeprazole enteric-coated tablets on gastric mucosal histopathology, gastric function, inflammatory cytokines, and Helicobacter pylori (H ...
Xue Pan
doaj +2 more sources
Iraqi Journal of Pharmaceutical Sciences, 2017 Wet granulation method was used instead of conventional pan coating or fluidized –bed coating technique to prepare enteric-coated diclofenac sodium granules, using ethanolic solution of EudragitTM L100 as coating, binding and granulating agent ...
Eman B. H. Al-Khedairy
doaj +5 more sources
Preformulation studies for generic omeprazole magnesium enteric coated tablets. [PDF]
Biomed Res Int, 2015 Preformulation is an important step in the rational formulation of an active pharmaceutical ingredient (API). Micromeritics properties: bulk density (BD) and tapped density (TD), compressibility index (Carr’s index), Hauser’s ratio (H), and sieve analysis were performed in order to determine the best excipients to be used in the formulation development
Migoha CO +3 more
europepmc +3 more sources
Absorption of enteric and non‐enteric coated prednisolone tablets. [PDF]
British Journal of Clinical Pharmacology, 1975 1. Relative rates of absorption of enteric and non‐enteric preparations of prednisolone were measured in five renal transplant recipients. 2. The absorption of the enteric coated preparation is delayed and the peak plasma concentration is much lower than that attained using the same dose of the uncoated material. 3.
B. Hulme, VH James, Raymond Rault
openalex +4 more sources
A Review on Enteric Coated Tablet
Journal of Biomedical and Pharmaceutical Research, 2022 Some of the purpose of tablet coating are masking flavour, fragrance overlapping, Environmental protection, prevent drug from gastric acid .Enteric coated tablets are solid unit dosage forms which are designed to bypass the stomach and release the drug in small intestine and are meant for oral administration.
Ashwani Kumar Singh +2 more
openalex +3 more sources
Nateglinide Controlled Release Tablet Containing Compressionable Enteric Coated Granules
CHEMICAL & PHARMACEUTICAL BULLETIN, 2010 We designed a single unit type controlled release tablet containing nateglinide to decrease both postprandial blood glucose level (PBG) and fasting blood glucose level (FBG) in normal beagle dogs. The tablet contains 60 mg of nateglinide in an immediate release portion, and 90 mg of nateglinide in a controlled release portion.
Chisato Makino +2 more
openalex +4 more sources